Navigation Links
Optimer Pharmaceuticals Appoints Hank McKinnell to Its Board of Directors
Date:1/10/2011

SAN DIEGO, Jan. 10, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced the appointment of Dr. Hank McKinnell to its Board of Directors.  Dr. McKinnell is the former Chief Executive Officer and former Chairman of the Board of Directors of Pfizer Inc.  He is currently Chairman of the Accordia Global Health Foundation, an organization dedicated to fighting infectious diseases in Africa, and is a member of the boards of Moody's Corporation, Angiotech Pharmaceutical, Inc., and privately-held Emmaus Medical, Inc.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

"Hank McKinnell's extensive business experience, deep interest in the opportunities of the biotech industry, and dedication to profound social advances to health and wellness for patients globally makes him a valuable addition to Optimer's Board of Directors," said Pedro Lichtinger, President and CEO of Optimer. "Our ability to attract someone with Hank's business acumen and demonstrated leadership talent is an inspiration to our team. His experience in economics, strategy and business operations has been instrumental in pioneering an approach for marrying innovation, health and wellness and market access as the essential formula for success in today's pharmaceutical marketplace.  We at Optimer will benefit from his tremendous skillset and insights."

"Optimer has a unique opportunity to drive some of the most exciting innovation in health care," said Dr. McKinnell.  "Fidaxomicin is a cutting edge antibiotic for c.diff, a bacterial infection putting increasing pressure on hospitals and placing the sick and elderly at particular risk, and addresses a growing health challenge with the aging of our population – especially as the first of the Baby Boomers turn 65 this Jan
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
4. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
5. Optimer Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
6. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
7. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
8. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
9. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
10. Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA
11. Optimer Pharmaceuticals to Host Investor and Analyst Event on November 18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015   Spirox Inc., a privately held ... an $18.5 million Series B round of financing led by ... Partners, Correlation Ventures and Western Technology Investment also ... a novel, minimally invasive system to be used ... plastic surgeons to treat patients with nasal obstruction, ...
(Date:4/20/2015)... and Markets ( http://www.researchandmarkets.com/research/7t5xlp/us_proton_therapy ) has announced ... - Market Opportunities" report to their offering. ... Opportunities by the author, the United States ... centers by 2018, a number which is almost double ... Billion dollar mark to attain revenue of US$ 1.19 ...
(Date:4/20/2015)... PITTSBURGH , April 20, 2015   ... PhD Research and Training Institute today expanded its ... include outpatient locations.  A $50,000 grant from the ... the research project possible.  The ... education to patients and their family members upon ...
Breaking Medicine Technology:Spirox, Inc. Announces Closing of $18.5MM Series B Financing 2Spirox, Inc. Announces Closing of $18.5MM Series B Financing 3United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 2United States Proton Therapy Outlook to 2018 - Market Opportunities for the $1.19 Billion Market Featuring IBA, Hitachi, Mevion Medical Systems & Varian 3Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 2Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations 3
... 18, 2011 Wolters Kluwer Pharma Solutions, Inc., a ... healthcare professionals, today announced strong impact factor (IF) ... drug therapy and patient management journals.  11 of the 13 ... in 2010 a ccording to the annual ...
... Kan., July 18, 2011 While much has ... the U.S., the impact is still being felt in the ... in patient visits over the last two years, while 42 ... 2009.  This decline continues a trend that has been documented ...
Cached Medicine Technology:Adis Journals Make Impressive Impact Factor Gains 2Adis Journals Make Impressive Impact Factor Gains 3Bayer Study Reveals Gaps in Perception of Veterinary Care Between Vets and Pet Owners 2Bayer Study Reveals Gaps in Perception of Veterinary Care Between Vets and Pet Owners 3Bayer Study Reveals Gaps in Perception of Veterinary Care Between Vets and Pet Owners 4Bayer Study Reveals Gaps in Perception of Veterinary Care Between Vets and Pet Owners 5
(Date:4/21/2015)... 2015 On Saturday, May 2nd, 2015, ... of his team from Georgia Eye Physicians and ... Lupus Now, being held in Piedmont Park by the ... to be the largest LFA-sponsored walk in the nation, ... raise funds and awareness for lupus, an unpredictable and ...
(Date:4/20/2015)... (PRWEB) April 21, 2015 When author ... (CFS), she felt as if nothing could wake her ... estimates that 250,000 U.K. citizens are currently living with CFS. ... action. Her new book, “ Living a Life Less Toxic ... Home, and Environment. Create a Happier, Healthier Life for You, ...
(Date:4/20/2015)... 21, 2015 Reality show stars, food, ... at the twentieth annual Michigan International Women’s Show, April ... , “There is lots to see and do from ... for fashion and gifts,” said Beth Anderson, executive show ... and encouraging with appearances from Randy Fenoli of ‘Say ...
(Date:4/20/2015)... 2015 Saint Joseph Regional Medical Center (SJRMC) ... Systems by Truven Health Analytics, a leading provider of information ... SJRMC has been recognized by Truven Health Analytics as a ... years. , According to Truven Health Analytics' analysis ... matchups with their peers, set the standard for care in ...
(Date:4/20/2015)... At the famous Avalon Hollywood on ... Awards” EcoLuxe Lounge, with Choices Recovery as the premier ... sustainable product placement in TV and film, gathered some ... ecologically sound goods and services for this daylong event. ... the Choices Celebrity Interview Lounge, speaking with many of ...
Breaking Medicine News(10 mins):Health News:9th Annual Walk to End Lupus Now 2Health News:9th Annual Walk to End Lupus Now 3Health News:New book by Faith Canter offers guide to banishing toxins 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 2Health News:Perfect Girls Day Out at Michigan International Women’s Show Opening Thursday, April 30 in Novi Presented by Southern Shows 3Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 2Health News:SJRMC Named a 15 Top Health System by Truven Health Analytics 3Health News:Choices Recovery South Bend Talks About Healthy Decisions with TV's Adrienne Janic 2
... Boston, Massachusetts has come out with findings that oral ... in a better way. ,Listing cases ... in the research, Dr Lawrence Shulman, of the Dana-Farber ... a consensus in the oncology field on standardized safeguards ...
... may be a case of being patronized, but Health Minister Andy ... ,Kerr is backing a 2.5 million pound campaign that will begin ... hands more often and this way combat the common cold, flu, ... MRSA. ,Says Kerr ‘It's a simple message, but washing ...
... sleep and heart disease is a two-way street: Poor ... can disturb sleep, reports the January 2007// issue of ... been linked with high blood pressure, atherosclerosis, heart failure, ... that ties these together may be inflammation, the body’s ...
... A pilot project that allowed prisoners a safe way to ... ended in September 2006. Now, an AIDS activist has urged ... of tattoo parlors in prison, as a method to check ... nearly 17% of the prisoners go in for tattoos or ...
... Little research exists demonstrating that testosterone is both safe ... dysfunction, reveal Mayo Clinic researchers in two new studies, ... ,Mayo Clinic physicians call for large studies ... when testosterone should be prescribed. ,"One of ...
... from food banks were found to be deficient in nutrients ... health of the deprived in the province, researchers from University ... Journal of Public Health, examined 180 food hampers, sourced from ... finding revealed that 99 per cent of the hampers, meant ...
Cached Medicine News:Health News:Watchdog to Be Set on Oral Chemotherapy, Warns Experts 2Health News:Better ‘Nannying’ Now Than Nev 2Health News:Benefits Of Testosterone Treatment 2